Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02355665 · ClinicalTrials.gov registry record · Phase 3
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
A Phase 3 study, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,198
- Enrollment target
NCT02355665: Completed Phase 3 study, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.
NCT02355665 is a Phase 3 study that has completed, run by McNeil Consumer Healthcare Division of McNEIL-PPC. The registered enrollment target is 1,198 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (55% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02355665, a Phase 3 study, has completed, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,198 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy and safety of a novel nicotine product for continuous abstinence from smoking. Efficacy of product will be evaluated by assessments of self-reported abstinence, verified by exhaled carbon monoxide (CO) levels.
Primary Outcome
Percentage of participants with carbon monoxide (CO)-verified self-report of continuous abstinence from smoking
Interventions
- DRUG Placebo
- DRUG Nicotine Spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,198 participants |
| Start Date | 2015-01-31 |
| Est. Completion | 2016-02-10 |
| Phase | Phase 3 |
What the finished NCT02355665 record still lists
NCT02355665 is an interventional study that assigns participants to a tested intervention. Its 1,198 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (55% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02355665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02355665 about?
NCT02355665 is a clinical study titled "Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy". The purpose of this study is to assess the efficacy and safety of a novel nicotine product for continuous abstinence from smoking. Efficacy of product will be evaluated by assessments of self-reported abstinence, verified by exhaled carbon monoxide (CO) levels.
What is the current status of trial NCT02355665?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,198 participants. The study started on 2015-01-31. Estimated completion is 2016-02-10.
What interventions are being tested in trial NCT02355665?
The interventions under investigation include: Placebo (DRUG), Nicotine Spray (DRUG).
Who is sponsoring clinical trial NCT02355665?
This trial is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02355665's enrollment target sits among peer trials
1,198 228th of 2000 higher than 1,773 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI